OraSure Technologies Inc (OSUR) Dividend History

OraSure Technologies Inc is a biotechnology company specializing in the development, manufacture, and distribution of point-of-care diagnostic tests and sample collection devices. It is known for its focus on infectious disease testing, including HIV, hepatitis, and COVID-19, as well as other health screening and diagnostic solutions. The company's products are used in both healthcare settings and for at-home testing.

220 E First St, Bethlehem, PA, 18015
Phone: (503) 641-6115
Website: https://www.orasure.com

Dividend History

OraSure Technologies Inc currently does not pay dividends

Company News

Global At-Home Testing Market to Reach USD 11,877.8 Million by 2035 with a CAGR of 4.8%, Driven by Rising Consumer Demand for Self-Diagnostic Tools | Future Market Insights, Inc.

The global at-home testing market is expected to grow from $7.8 billion in 2025 to $11.9 billion by 2035, driven by increasing consumer demand for self-diagnostic tools. Key factors include rising healthcare spending, growing awareness of preventive healthcare, and technological advancements in diagnostic tools.

GlobeNewswire Inc.

Featured Companies: ABT
OraSure Technologies Acquires Sherlock Biosciences

OraSure Technologies has acquired Sherlock Biosciences, a global health company that develops next-generation diagnostic tests. The acquisition expands OraSure's pipeline with Sherlock's molecular diagnostics platform, which can provide rapid and accurate results for sexually transmitted infections.

Benzinga
Microbiome Diagnostics Market to hit USD 429.2 million by 2032, says Global Market Insights Inc.

The microbiome diagnostics industry is projected to grow at a CAGR of 13.4% from 2024 to 2032, driven by the rising demand for personalized medicine. Advancements in sequencing technologies and collaborations between research organizations are expected to drive the market.

GlobeNewswire Inc.

Featured Companies: BDX ILMN QGEN
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology

The global infectious disease diagnostics market is projected to reach $43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period. The market is driven by advancements in diagnostic technologies, rising cases of infectious diseases, and increased R&D funding.

Benzinga

Featured Companies: ABT BDX BIO BIO.B CODX DHR QDEL QGEN RVTY TMO
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th - GlobeNewswire

OraSure Technologies, Inc. has scheduled its Q2 2024 earnings conference call for August 6, 2024. The webcast will be available on the company's investor relations website.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 20:35:03 UTC